Clinical Trials Browser

Interventional × Gastrointestinal Neoplasms × Imatinib Mesylate × Clear all

NCT00867113 2018-03-14

Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)

Phase 2 Completed

91 enrolled 11 charts

GastrointestinalSarcoma

Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

NCT02013089 2016-08-30

GITIC

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms